Paradigm Financial Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$407K Sell
4,437
-705
-14% -$84.3K 0.09% 138
2021
Q3
$652K Sell
5,142
-110
-2% -$16K 0.15% 101
2021
Q2
$873K Sell
5,252
-115
-2% -$18.6K 0.19% 90
2021
Q1
$975K Buy
5,367
+488
+10% +$113K 0.24% 81
2020
Q4
$976K Buy
4,879
+489
+11% +$99.4K 0.26% 73
2020
Q3
$962K Sell
4,390
-250
-5% -$52.9K 0.27% 57
2020
Q2
$885K Buy
4,640
+117
+3% +$20.5K 0.28% 59
2020
Q1
$701K Buy
4,523
+1,303
+40% +$152K 0.26% 64
2019
Q4
$270K Buy
+3,220
New +$245K 0.09% 106

Other funds holding TDOC

Paradigm Financial Advisors's TDOC Position: Q4 2021 in Review

Paradigm Financial Advisors reduced its Teladoc Health (TDOC) stake by 14% in Q4 2021, selling an estimated $84.3K and leaving 4,437 shares worth $407K. The position accounts for 0.09% of the portfolio, ranked #138.

Paradigm Financial Advisors first reported a position in TDOC in Q4 2019 and has held it in 9 quarters since. The position peaked at $976K in Q4 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Paradigm Financial Advisors held 4,437 shares of Teladoc Health worth $407K as of Q4 2021.
  • Paradigm Financial Advisors sold 705 Teladoc Health shares in Q4 2021, an estimated $84.3K.
  • Teladoc Health made up 0.09% of Paradigm Financial Advisors's portfolio in Q4 2021, its #138 holding.
  • Paradigm Financial Advisors first reported a position in Teladoc Health in Q4 2019 and has held it in 9 quarters since.
  • Paradigm Financial Advisors's Teladoc Health position peaked at $976K in Q4 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Paradigm Financial Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.